Porcine Acellular Dermal Matrix for the Treatment of Localized Gingival Recessions

NCT06006780 — Not applicable, Completed, 40 participants, University of Campinas, Brazil

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Porcine Acellular Dermal Matrix for the Treatment of Localized Gingival Recessions: A Multicenter Randomized Clinical Trial

RegistryNCT06006780
StatusCompleted
PhaseNot applicable
Study typeInterventional; randomized, parallel, masking: quadruple, treatment
Enrollment40 (Actual)
SponsorUniversity of Campinas, Brazil (Other)
ConditionsGingival Recession
InterventionsPorcine acellular dermal matrix, Coronally advanced flap (CAF) (Device, other)
Datesstart 2022-09-10, primary completion 2024-12-30, completion 2024-12-30, first posted 2023-08-23, last updated 2025-04-02
Locations1 site in Brazil

Related Papers Related Patents Related Grants Related Experts
All trials for Gingival Recession All trials of Porcine acellular dermal matrix All trials of Coronally advanced flap (CAF)

-Summary

Aim: The aim of this randomized clinical trial is to evaluate the use of the porcine acellular dermal matrix (PADM) for the treatment of RT1 localized gingival recessions.

Material and methods: Forthy patients (n=20) with RT1 localized gingival recessions with height ranging from 3 to 5 mm with and at least, 2mm of keratinized tissue width will be selected to participate in the study. Patients will be allocated randomly in two treatment groups: Coronally advanced flap (CAF) or coronally advanced flap associated with the porcine acellular dermal matrix (CAF+ PADM). The clinical parameters evaluated at the baseline, 6 and 12 months will be: Plaque index (IPL); gingival index (GI); relative gingival recession height (RGRH); gingival recession width (GRW); probing depth (PD); relative clinical attachment level (RCAL); keratinized tissue height (KTH); keratinized tissue thickness (KTT); papilla height (PH). Evaluations will be made by the professional and the patient regarding dentin hypersensitivity (HD) (Schiff and VAS scales respectively), aesthetics (RES and VAS scales, respectively) and patient\'s centered outcomes, through the questionnaire referring to the OHIP-14.

Descriptive statistical analysis will be expressed as mean ± standard deviation (SD), median, quartiles, percentages and confidence intervals (95% CI). To analyze the normality of the residue, the Shapiro-Wilk test will be performed. Then, the Wilcoxon test will be applied to compare the periodontal parameters and a quality of life, before and post-treatment. Correlations between parameters and dental hypersensitivity will be analyzed through Spearman\'s test. Key words: Gingival recession, Root coverage, Biomaterial, Acellular dermal matrix.

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
Coronally advanced flap (CAF)Active comparatorOther: Coronally advanced flap (CAF)
Coronally advanced flap associated with the porcine acellular dermal matrix (CAF+ PADM)ExperimentalDevice: Porcine acellular dermal matrix
  • Porcine acellular dermal matrix (Device), also known as Mucoderm: Coronally advanced flap associated with the porcine acellular dermal matrix for root coverage
  • Coronally advanced flap (CAF) (Other): Coronally advanced flap for root coverage

+Outcome measures

Primary outcomes

  • Recession change [Baseline, 6 months and 12 months]: Change of the gingival recession height

Secondary outcomes

  • Thickness of keratinized tissue [Baseline, 6 months and 12 months]: Thickness of keratinized tissue evaluation after periodontal plastic surgery

+Eligibility

Sex: All, ages: 18 Years to 60 Years, accepts healthy volunteers

Inclusion Criteria:

* RT1 localized gingival recessions with height ranging from 3 to 5 mm;
* 2mm or more of keratinized tissue width ;
* Probing depth less than 3mm;
* Plaque and gingival index less or equal to 20%.

Exclusion Criteria:

* Smokers;
* Pregnants;
* Nursing;
* Patients with diabetes mellitus or another condition that interfere in the tissue repair
* Patients who use drugs or medications that interfere in the tissue repair;
* Allergies to any composition of the devices of the study.

+Locations (1)

FacilityCityCountryStatus
Piracicaba Dental School, State University of CampinasPiracicaba, São PauloBrazil

+Publications

  • Results publication: Sangiorgio JPM, Neves FLDS, Rocha Dos Santos M, Franca-Grohmann IL, Casarin RCV, Casati MZ, Santamaria MP, Sallum EA. Xenogenous Collagen Matrix and/or Enamel Matrix Derivative for Treatment of Localized Gingival Recessions: A Randomized Clinical Trial. Part I: Clinical Outcomes. J Periodontol. 2017 Dec;88(12):1309-1318. doi: 10.1902/jop.2017.170126. Epub 2017 Jul 28. PMID 28753100